These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6214261)

  • 21. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forty-seven years experience with gold therapy in 1,019 rheumatoid arthritis patients.
    Lockie LM; Smith DM
    Semin Arthritis Rheum; 1985 May; 14(4):238-46. PubMed ID: 2934818
    [No Abstract]   [Full Text] [Related]  

  • 23. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA; McConkey B
    Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proceedings: Eosinophilia during gold therapy.
    Jessop JD; Dippy J; Turnbull A; Bright M
    Rheumatol Rehabil; 1974 May; 13(2):75-80. PubMed ID: 4276506
    [No Abstract]   [Full Text] [Related]  

  • 25. Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods.
    Kean WF; Anastassiades TP
    Arthritis Rheum; 1979 May; 22(5):495-501. PubMed ID: 156026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole.
    Husain Z; Runge LA
    J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of penicillamine and gold treatment in early rheumatoid arthritis.
    Mäkisara P; Nissilä M; Kajander A; Martio J; von Essen R; Anttila P; Mäkisara GL
    Scand J Rheumatol; 1978; 7(3):166-70. PubMed ID: 103190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
    Bird HA
    Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
    Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
    Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
    Jellum E; Aaseth J; Munthe E
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
    [No Abstract]   [Full Text] [Related]  

  • 33. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
    Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC
    Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects of D-penicillamine in rheumatoid arthritis.
    Stein HB; Patterson AC; Offer RC; Atkins CJ; Teufel A; Robinson HS
    Ann Intern Med; 1980 Jan; 92(1):24-9. PubMed ID: 7350870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the order of second-line treatment in rheumatoid arthritis matter?
    Steven MM; Hunter JA; Murdoch RM; Capell HA
    Br Med J (Clin Res Ed); 1982 Jan; 284(6309):79-81. PubMed ID: 6797663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: D-penicillamine in rheumatoid arthritis.
    Lancet; 1975 May; 1(7916):1123-5. PubMed ID: 49477
    [No Abstract]   [Full Text] [Related]  

  • 37. An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy.
    Webley M; Coomes EN
    J Rheumatol; 1979; 6(1):20-4. PubMed ID: 439106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
    Haataja M; Nissilä M; Ruutsalo HM
    Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.